Artal International Management S.A. — SEC Form 4 filings
SEC reporting owner CIK 1522131. 11 Form 4 filings on record with FilingPulse; latest filed 2026-06-17.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-02-29 to 2026-06-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 1,538,462 shares, $2,000,001 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 6 legs across 6 filings — 25,500,000 shares, $2,623,950,000 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: sale of 8,000,000 shares @ $134.13 ($1,073,040,000) in CAVA GROUP, INC., filed 2024-11-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CAVA GROUP, INC. (CAVA) | Director | 6 | — | 6 legs · 25,500,000 sh · $2,623,950,000 | — |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | Director, 10% owner | 5 | 1 leg · 1,538,462 sh · $2,000,001 | — | 11 |
Form 4 filings — Artal International Management S.A.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-17 | 4 | CAVA GROUP, INC. (CAVA) jointly with Artal Participations S.a r.l., Artal International S.C.A., Artal Group S.A., Westend S.A., Stichting Administratiekantoor Westend, Wittouck Amaury | Sale (S): 3,000,000 @ $90.30 | EDGAR |
| 2026-05-08 | 4 | LEXICON PHARMACEUTICALS, INC. (LXRX) jointly with Artal Participations S.a r.l., Artal International S.C.A., Artal Group S.A., Westend S.A., Stichting Administratiekantoor Westend, Wittouck Amaury | Option exercise (M): 20,421,735 @ $0 · Grant/award (A): 408,434.70 (derivative) · Option exercise (M): 408,434.70 (derivative) @ $0 | EDGAR |
| 2026-02-19 | 4 | LEXICON PHARMACEUTICALS, INC. (LXRX) jointly with Artal Participations S.a r.l., Artal International S.C.A., Artal Group S.A., Westend S.A., Stichting Administratiekantoor Westend, Wittouck Amaury | Grant/award (A): 41,289.58 @ $65 | EDGAR |
| 2026-02-04 | 4 | LEXICON PHARMACEUTICALS, INC. (LXRX) jointly with Invus Global Management, LLC, Siren, L.L.C., DEBBANE RAYMOND, Artal Participations S.a r.l., Artal International S.C.A., Artal Group S.A., Westend S.A., Stichting Administratiekantoor Westend | Grant/award (A): 18,553,846 @ $1.30 · Grant/award (A): 3,846,154 @ $1.30 · Purchase (P): 1,538,462 @ $1.30 · Grant/award (A): 367,145.12 @ $65 | EDGAR |
| 2024-11-20 | 4 | CAVA GROUP, INC. (CAVA) jointly with Artal International S.C.A., Artal Group S.A., Westend S.A., Stichting Administratiekantoor Westend, Wittouck Amaury | Sale (S): 8,000,000 @ $134.13 | EDGAR |
| 2024-08-28 | 4 | CAVA GROUP, INC. (CAVA) jointly with Artal International S.C.A., Artal Group S.A., Westend S.A., Stichting Administratiekantoor Westend, Wittouck Amaury | Sale (S): 6,000,000 @ $116.36 | EDGAR |
| 2024-06-07 | 4 | CAVA GROUP, INC. (CAVA) jointly with Artal International S.C.A., Artal Group S.A., Westend S.A., Stichting Administratiekantoor Westend, Wittouck Amaury | Sale (S): 3,000,000 @ $87.25 | EDGAR |
| 2024-05-14 | 4 | LEXICON PHARMACEUTICALS, INC. (LXRX) jointly with Artal International S.C.A., Wittouck Amaury, Artal Group S.A., Westend S.A., Stichting Administratiekantoor Westend, Invus Public Equities, L.P., Invus, L.P., Invus Public Equities Advisors, LLC, Invus Advisors, L.L.C. | Option exercise (M): 57,546,100 · Grant/award (A): 1,150,922 (derivative) @ $108.50 · Option exercise (M): 1,150,922 (derivative) @ $0 | EDGAR |
| 2024-03-25 | 4 | CAVA GROUP, INC. (CAVA) jointly with Artal International S.C.A., Artal Group S.A., Westend S.A., Stichting Administratiekantoor Westend, Wittouck Amaury | Sale (S): 2,000,000 @ $66.25 | EDGAR |
| 2024-03-13 | 4 | LEXICON PHARMACEUTICALS, INC. (LXRX) jointly with Artal International S.C.A., Wittouck Amaury, Artal Group S.A., Westend S.A., Stichting Administratiekantoor Westend, Invus Public Equities, L.P., Invus, L.P., Invus Public Equities Advisors, LLC, Invus Advisors, L.L.C. | Grant/award (A): 1,150,922 @ $108.50 | EDGAR |
| 2024-02-29 | 4 | CAVA GROUP, INC. (CAVA) jointly with Artal International S.C.A., Artal Group S.A., Westend S.A., Stichting Administratiekantoor Westend, Wittouck Amaury | Sale (S): 3,500,000 @ $53.60 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1522131 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →